Full data view for gene GCDH

Variant classification: please note that where there are several records of the same variant, classification of that variant
may differ between records depending on the reporting publication or the submitter's opinion. For the curator’s opinion on
the classification, please view the SUMMARY record or the concluded functional effect (value in column Effect after the /).
Information The variants shown are described using the NM_000159.3 transcript reference sequence.

11 entries on 1 page. Showing entries 1 - 11.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+/+ 11 c.1173del r.1173del p.Asn392Metfs*9 Both (homozygous) - pathogenic (recessive) g.13008607del g.12897793del - - GCDH_000148 fibroblast GCD activity undetectable PubMed: Anikster 1996 - - Germline - 1 - - - DNA, RNA RT-PCR, SEQ - - GA1 08900228-Fam1 II.4/ Table 1, Pat 1 PubMed: Amir 1989, PubMed: Anikster 1996 This patient was first described by Amir 1989 (kindred 1, generation IV, pat 4) and later again by Anikster (family 1, II-4) who also identified the mutation Family: Three siblings: one homozygous but asyptomatic brother (LOVD Indiv ID: 00000943), two sisters (one healthy, one a carrier); For pedigree see full texts M yes Israel Jewish;Kurdistan 08y - - - 1 Katrin Hinderhofer
+/+ 11 c.1173del r.1173del p.Asn392Metfs*9 Both (homozygous) - pathogenic (recessive) g.13008607del g.12897793del - - GCDH_000148 - PubMed: Anikster 1996 - - Germline - 1 - - - DNA, RNA RT-PCR, SEQ - - - 08900228-Fam1 II.3 PubMed: Amir 1989, PubMed: Anikster 1996 This patient was first described by Amir 1989 (kindred 1, generation IV, pat 3) and later again by Anikster 1996 (family 1, II-3) who also identified the mutation; Family: One affected brother (LOVD Indiv ID: 00000935), one carrier sister; For pedigree see full texts M yes Israel Jewish;Kurdistan - - - - 1 Katrin Hinderhofer
+/+ 11 c.1173del r.1173del p.Asn392Metfs*9 Unknown - pathogenic (recessive) g.13008607del g.12897793del - - GCDH_000148 unaffected carrier PubMed: Anikster 1996 - - Germline/De novo (untested) - 3 - - - DNA SEQ - - - - PubMed: Anikster 1996 2nd chromosome is normal / 2-generation family1, unaffected carrier parents and sister - yes Israel Jewish;Kurdistan - - - - 3 Katrin Hinderhofer
+/+ 11 c.1173del r.(?) p.(Asn392Metfs*9) Unknown - pathogenic (recessive) g.13008607del g.12897793del c.1209delG - GCDH_000148 - PubMed: Busquets 2000 - - Germline/De novo (untested) - - - - - DNA SEQ, SSCA - - GA1 - PubMed: Busquets 2000 - ? ? Spain - - - - - 1 Svenja Wagner
+/+ 11 c.1173del r.(?) p.(Asn392Metfs*9) Unknown - pathogenic (recessive) g.13008607del g.12897793del c.1209delG - GCDH_000148 - PubMed: Busquets 2000 - - Germline/De novo (untested) - - - - - DNA SEQ, SSCA - - GA1 - PubMed: Busquets 2000 - ? ? Spain - - - - - 1 Svenja Wagner
+/+ 11 c.1173del r.(?) p.(Asn392Metfs*9) Unknown - pathogenic (recessive) g.13008607del g.12897793del c.1209delG - GCDH_000148 - PubMed: Busquets 2000 - - Germline/De novo (untested) - - - - - DNA SEQ, SSCA - - GA1 10960496-Pat.41 PubMed: Busquets 2000 - ? ? Spain - - - - - 1 Svenja Wagner
+/+ 11 c.1173del r.(?) p.(Asn392Metfs*9) Unknown - pathogenic (recessive) g.13008607del g.12897793del - - GCDH_000148 - PubMed: Gupta 2015 - - Germline/De novo (untested) - - - - - DNA SEQ blood - GA1 25762492-F15 PubMed: Gupta 2015 - M ? India - - - - - 1 Isabelle Rinke
+/+ 11 c.1173del r.(?) p.(Asn392Metfs*9) Unknown - pathogenic (recessive) g.13008607del g.12897793del - - GCDH_000148 - PubMed: Busquets 2000 - - Germline/De novo (untested) - - - - - DNA PCR, SEQ, SSCA blood or cultured fibroblasts - GA1 10960496-Pat.19 PubMed: Busquets 2000 This patient has been described before (either by Prats 1993 or Merinero 1995) ? ? Spain - - - - - 1 Isabelle Rinke
+/+ 11 c.1173del r.1173del p.Asn392Metfs*9 Unknown ACMG pathogenic g.13008607del g.12897793del - - GCDH_000148 ACMG/ACGS: PS4_Moderate, PM3_Strong, PP4_Moderate, PVS1, PM2_Supporting (December 2024) - - - SUMMARY record - - - - - - - - - - - - - - - - - - - - - - -
+/+ 11 c.1173del r.(?) p.(Asn392Metfs*9) Unknown - pathogenic (recessive) g.13008607del g.12897793del c.1173delG - GCDH_000148 - PubMed: Sitta 2021 - - Germline/De novo (untested) - 1/48 (alleles) - - - DNA PCR, SEQ dried blood spots - GA1 Pat7 PubMed: Sitta 2021 - M no Brazil - - - - all patients diagnosed in the authors laboratory were immediately submitted to the available treatment based on protein (lysine) restricted diets and L-carnitine supplementation 1 Sabrina Oeser
+/+ 11 c.1173del r.(?) p.(Asn392Metfs*9) Both (homozygous) - pathogenic (recessive) g.13008607del g.12897793del - - GCDH_000148 - PubMed: Tamhankar 2021 - - Germline - - - - - DNA PCR, SEQ peripheral blood - GA1 34504725-ID6 PubMed: Tamhankar 2021 parents heterozygous carriers ? yes India - - - - carnitine supplementation+low protein diet (lys&tryp).100mg L-carnitine/kg per day; carnitine 100mg/kg/day, riboflavin 100mg per day, pacitane (trihexyphenidyl) for severe dystonia,&protein-restricted diet with restriction on lys rich food 1 Sabrina Oeser
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.